Mannose conjugated polymer binding in the p. Aeruginosa biofilm

Keyphrases

• Antibiotics 100%
• Mannose 100%
• Pseudomonas Aeruginosa Infection 100%
• Biofilm 100%
• Polymer Bound 100%
• Conjugated Polymers 100%
• Mucoid Phenotype 100%
• Aeruginosa 100%
• Respiratory Failure 50%
• Twice Daily 50%
• Chronic Infection 50%
• Cystic Fibrosis 50%
• Current Treatment 50%
• Patient Well-being 50%
• Immune Evasion 50%
• Antibiotic Resistance 50%
• Pseudomonas Aeruginosa (P. aeruginosa) 50%
• Recurring 50%
• Lung Function 50%
• Prodrug 50%
• Biomaterials 50%
• Treatment Burden 50%
• Treatment Cycle 50%
• Pseudomonas Aeruginosa Biofilm 50%
• Respiratory Death 50%
• Statement of Purpose 50%
• Tobramycin 50%
• Repeated Treatment 50%
• Drug-polymer 50%
• Nonmucoid 50%
• Inhalable 50%

Pharmacology, Toxicology and Pharmaceutical Science

• Infection 100%
• Mannose 100%
• Pseudomonas aeruginosa 66%
• Pseudomonas Infection 66%
• Respiratory Failure 33%
• Antibiotics 33%
• Cystic Fibrosis 33%
• Antibiotic Resistance 33%
• Antibiotic Agent 33%
• Deterioration 33%
• Prodrug 33%
• Biomaterial 33%
• Tobramycin 33%